Navigation Endo's Bankruptcy Pauses Pa.'s Coordinated Opioid Litigation
The pharma company’s petition raises questions as to who will lead the defense team in the matter, which has already been criticized as progressing at a slow pace.
The pharma company’s petition raises questions as to who will lead the defense team in the matter, which has already been criticized as progressing at a slow pace.
